Chancellor Rachel Reeves Plans Targeted Action on Living Costs in Upcoming Financial Plan

Treasury head Rachel Reeves has revealed she is planning "specific measures to address cost of living pressures" in the upcoming financial statement.

Speaking to media outlets, she stated that reducing inflation is a shared responsibility of both the administration and the central bank.

The United Kingdom's price growth is projected to be the highest among the Group of Seven advanced economies this year and next.

Potential Utility Cost Measures

It is understood the government could intervene to lower utility costs, for instance by reducing the present 5% rate of VAT applied on energy.

An additional approach is to reduce some of the regulatory levies presently included in household expenses.

Budgetary Constraints and Analyst Expectations

The government will receive the next assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much scope there is for these measures.

The consensus from the majority of experts is that the Chancellor will have to introduce higher taxes or budget cuts in order to meet her self-imposed fiscal targets.

Earlier on the same day, analysis showed there was a £22 billion deficit for the chancellor to fill, which is at the lower end of projections.

"There's a shared responsibility between the central bank and the administration to bear down further on some of the sources of inflation," the Chancellor informed the BBC in the US capital, at the yearly gatherings of the IMF and global financial institution.

Revenue Pledges and Global Concerns

While a great deal of the attention has been on expected tax rises, the Treasury chief said the most recent data from the OBR had not altered her commitment to manifesto promises not to raise tax levels on income tax, VAT or social security contributions.

She attributed an "uncertain world" with rising geopolitical and commercial tensions for the fiscal tax moves, likely to be directed on those "most able to pay."

Global Trade Tensions

Commenting on concerns about the UK's commercial links with China she said: "Our security interests always take priority."

Recent announcement by Chinese authorities to increase trade restrictions on critical minerals and other resources that are key for high-technology manufacturing led American leader Donald Trump to threaten an extra 100% import tax on imports from the Asian country, increasing the prospect of an all-out trade war between the two largest economies.

The US Treasury Secretary labeled the Chinese decision "economic coercion" and "a global supply chain control attempt."

Asked about accepting the US offer to participate in its conflict with the Asian nation, Reeves said she was "deeply worried" by China's actions and encouraged the Chinese government "not to put up barriers and restrict access."

She said the action was "bad for the world economy and causes further obstacles."

"It is my opinion there are fields where we must confront China, but there are also important prospects to trade with China's economy, including financial services and other areas of the economy. We've got to achieve that balance right."

The chancellor also confirmed she was collaborating with other major economies "on our own critical minerals plan, so that we are more independent."

Health Service Drug Costs and Funding

The Chancellor also acknowledged that the cost the National Health Service pays for drugs could rise as a consequence of ongoing talks with the US government and its pharmaceutical firms, in exchange for lower tariffs and capital.

A number of the biggest global pharmaceutical manufacturers have said in recent statements that they are either delaying or abandoning operations in the United Kingdom, with some attributing the low prices they are receiving.

Last month, the Science Minister said the cost the NHS spends on medicines would have to rise to halt firms and pharmaceutical investment leaving the United Kingdom.

The Chancellor stated to media: "It has been observed as a result of the cost structure, that drug testing, innovative medicines have not been available in the UK in the extent that they are in other European countries."

"Our aim is to make sure that individuals getting care from the NHS are can receive the top life-saving treatments in the globe. And so we are examining these issues, and... seeking to secure additional capital into Britain."